Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT00103285 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00103285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
April 11, 2005
Completion date
March 31, 2021
Enrollment
5,377 (actual)
Sites
236

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, childhood b acute lymphoblastic leukemia